Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Cassandra Duarte MD

Cassandra Duarte MD

Hematology/Oncology Fellow, Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado

Cassandra Duarte, MD, is the chief hematology/oncology fellow at the University of Colorado School of Medicine. She is interested in aggressive B-cell lymphomas and the impact of TP53 alterations on clinical outcomes. She plans on caring for aggressive B-cell lymphoma patients and conducting translational research to investigate molecular markers of high risk disease with the goal of finding novel targets for therapies.

Disclosures

Dr. Duarte is on the Advisory Board for  EMD Serono and Cogent Biosciences.

Recent Contributions to PracticeUpdate:

  1. Zanubrutinib, Obinutuzumab, and Venetoclax as a First-Line Treatment for TP53-Mutant Mantle Cell Lymphoma

Most Read This Week

Recently Updated